SATB1 is an independent prognostic marker for gastric cancer in a Chinese population

Oncology Reports

Volumn 24, Issue 4, 2010, Pages 981-987

  Lu, Xiaoming ^a   Cheng, Chao ^a   Zhu, Shikai ^a   Yang, Yun ^a   Zheng, Liduan ^a   Wang, Guobin ^a   Shu, Xiaogang ^a   Wu, Ke ^a   Liu, Ke ^a   Tong, Qiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gastric cancer; Metastasis; Prognosis; SATB1

Indexed keywords

BINDING PROTEIN; MESSENGER RNA; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CHINESE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957360771     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000945     Document Type: Article

References (35)

1. Terry MB, Gaudet MM and Gammon MD: The epidemiology of gastric cancer. Semin Radiat Oncol 12: 111-127, 2002.
2. Sakamoto J, Morita S, Kodera Y, Rahman M and Nakao A: Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives. Cancer Chemother Pharmacol 54: 25-31, 2004.
3. Fuchs CS and Mayer RJ: Gastric carcinoma. N Engl J Med 333: 32-41, 1995.
4. Alberts SR, Cervantes A and van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14 (Suppl. 2): 31-36, 2003.
5. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
6. Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477, 2009.
7. Li K and Lu J: Research advances of SATB1 on gene expression and regulation. Chin Bull Life Sci 17: 315-317, 2005.
8. Yamaguchi H, Tateno M and Yamasaki K: Solution structure and DNA-binding mode of the matrix attachment regionbinding domain of the transcription factor SATB1 that regulates the T-cell maturation. J Biol Chem 281: 5319-5327, 2006.
9. Kumar PP, Bischof O, Purbey PK, Notani D, Urlaub H, Dejean A and Galande S: Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 9: 45-56, 2007.
10. Cai S, Han HJ and Kohwi-Shigematsu T: Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34: 42-51, 2003.
11. Cai S, Lee CC and Kohwi-Shigematsu T: SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38: 1278-1288, 2006.
12. Dickinson LA, Joh T, Kohwi Y and Kohwi-Shigematsu T: A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70: 631-645, 1992.
13. Patani N, Jiang W, Mansel R, Newbold R and Mokbel K: The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int 9: 18-27, 2009.
14. Zhou LY, Liu F, Tong J, Chen QQ and Zhang FW: Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer. Nan Fang Yi Ke Da Xue Xue Bao 29: 534-537, 2009.
15. Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ and Wang LL: Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 72: 1-5, 2010.
16. Han HJ, Russo J, Kohwi Y and Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187-193, 2008.
17. Omejc M, Juvan R, Jelenc F and Repse S: Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg 86: 14-19, 2001.
18. Ogawa K, Utsunomiya T, Mimori K, et al: Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 11: 2889-2893, 2005.
19. Bièche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R and Vidaud M: Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 45: 1148-1156, 1999.
20. Siewert JR, Böttcher K, Stein HJ and Roder JD: Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449-461, 1998.
21. Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N and Kitano S: Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 89: 1418-1424, 2000.
22. Tahara E: Molecular aspects of invasion and metastasis of stomach cancer. Verh Dtsch Ges Pathol 84: 43-49, 2000.
23. Xie K and Huang S: Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis 20: 31-43, 2003.
24. Galande S, Purbey PK, Notani D and Kumar PP: The third dimension of gene regulation: organization of dynamic chromatin loopscape by SATB1. Curr Opin Genet Dev 17: 408-414, 2007.
25. Yasui D, Miyano M, Cai S, Varga-Weisz P and Kohwi-Shigematsu T: SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419: 641-645, 2002.
26. Burbano RR, Assumpção PP, Leal MF, et al: C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. Anticancer Res 26: 2909-2914, 2006.
27. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY and Kohwi- Shigematsu T: The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 14: 521-535, 2000.
28. Wang CS, Lin KH, Chen SL, Chan YF and Hsueh S: Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance. Br J Cancer 91: 1924-1930, 2004.
29. Li K, Cai R, Dai BB, et al: SATB1 regulates SPARC expression in K562 cell line through binding to a specific sequence in the third intron. Biochem Biophys Res Commun 356: 6-12, 2007.
30. Steeg PS: Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3: 55-63, 2003.
31. Yu GZ, Chen Y, Ni CR, Wang GD, Qian JX and Wang JJ: Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer. Int J Exp Pathol 88: 175-183, 2007.
32. Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T and Sugihara K: Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann Surg Oncol 14: 2738-2747, 2007.
33. Kouraklis G, Katsoulis IE, Theocharis S, et al: Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma? Dig Dis Sci 54: 1015-1020, 2009.
34. Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, Liu XP and Xu ZD: Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci 101: 80-86, 2010.
35. Weber GF: The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 1552: 61-85, 2001.